<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PID Management Algorithm</title>
    <style>
        /* --- Global Styles & Variables --- */
        :root {
            --primary-color: #005a9c; /* Professional Blue */
            --secondary-color: #e6f0f6;
            --accent-color: #00aaff;
            --danger-color: #d9534f;
            --danger-light-color: #fbebeb;
            --warning-color: #f0ad4e;
            --success-color: #5cb85c;
            --text-color: #333;
            --light-text-color: #555;
            --bg-color: #f9f9f9;
            --border-color: #e0e0e0;
            --card-bg-color: #ffffff;
            --shadow: 0 4px 12px rgba(0, 0, 0, 0.08);
            --border-radius: 8px;
        }

        @import url('https://fonts.googleapis.com/css2?family=Lato:wght@400;700&display=swap');

        body {
            font-family: 'Lato', -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            margin: 0;
            padding: 2rem 1rem;
            background-color: var(--bg-color);
            color: var(--text-color);
            line-height: 1.6;
        }

        /* --- Layout --- */
        .container {
            max-width: 1000px;
            margin: auto;
            display: grid;
            gap: 2rem;
        }
        
        header {
            text-align: center;
            margin-bottom: 1rem;
        }

        header h1 {
            color: var(--primary-color);
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
        }

        header p {
            font-size: 1.1rem;
            color: var(--light-text-color);
            max-width: 700px;
            margin: auto;
        }
        
        .card {
            background: var(--card-bg-color);
            border-radius: var(--border-radius);
            box-shadow: var(--shadow);
            border-left: 5px solid var(--primary-color);
            padding: 1.5rem 2rem;
            transition: transform 0.2s ease, box-shadow 0.2s ease;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 20px rgba(0, 0, 0, 0.1);
        }

        .card h2 {
            font-size: 1.6rem;
            color: var(--primary-color);
            margin-top: 0;
            padding-bottom: 0.75rem;
            border-bottom: 2px solid var(--secondary-color);
        }
        
        .card h3 {
            font-size: 1.2rem;
            color: #333;
            margin-top: 1.5rem;
            margin-bottom: 0.5rem;
        }

        /* Specific Card Styles */
        .card.red-flag {
            border-left-color: var(--danger-color);
        }
        .card.red-flag h2 {
            color: var(--danger-color);
        }
        
        .card.management {
            border-left-color: var(--success-color);
        }
        .card.management h2 {
            color: var(--success-color);
        }
        
        /* --- Lists --- */
        ul {
            list-style: none;
            padding-left: 0;
        }

        ul li {
            position: relative;
            padding-left: 25px;
            margin-bottom: 0.75rem;
        }

        ul li::before {
            content: 'âœ“';
            position: absolute;
            left: 0;
            color: var(--primary-color);
            font-weight: bold;
        }
        
        /* --- Tables --- */
        table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 1rem;
        }
        
        th, td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid var(--border-color);
        }
        
        thead th {
            background-color: var(--secondary-color);
            color: var(--primary-color);
            font-weight: 700;
        }

        tbody tr:nth-of-type(even) {
            background-color: #fafafa;
        }
        
        tbody tr:hover {
            background-color: #f1f1f1;
        }

        /* --- Helper Classes --- */
        .highlight {
            background-color: var(--secondary-color);
            padding: 2px 6px;
            border-radius: 4px;
            font-weight: 700;
        }

        .warning-text {
            background-color: #fff9e6;
            border-left: 4px solid var(--warning-color);
            padding: 1rem;
            margin-top: 1rem;
            border-radius: 0 4px 4px 0;
            font-size: 0.95rem;
        }
        
        footer {
            text-align: center;
            margin-top: 2rem;
            color: var(--light-text-color);
            font-size: 0.9rem;
        }

        /* --- Responsive Design --- */
        @media (max-width: 768px) {
            body {
                padding: 1rem 0.5rem;
            }
            .card {
                padding: 1rem 1.25rem;
            }
            header h1 {
                font-size: 2rem;
            }
        }
    </style>
</head>
<body>

    <div class="container">
        <header>
            <h1>Pelvic Inflammatory Disease (PID)</h1>
            <p>A one-page clinical algorithm for rapid assessment and management in primary care.</p>
        </header>

        <div class="card">
            <h2>1. Assessment & Diagnosis</h2>
            <p>Maintain a low threshold for empirical treatment. Diagnosis is clinical; do not delay for test results.</p>
            <h3>Key Symptoms (Recent Onset)</h3>
            <ul>
                <li>Bilateral lower abdominal or pelvic pain</li>
                <li>Deep dyspareunia (painful intercourse)</li>
                <li>Abnormal vaginal bleeding (intermenstrual or postcoital)</li>
                <li>Abnormal vaginal/cervical discharge</li>
            </ul>
            <h3>Key Examination Findings</h3>
            <ul>
                <li>Pelvic tenderness on bimanual exam (cervical motion, uterine, or adnexal)</li>
                <li>Mucopurulent discharge or cervical friability on speculum exam</li>
            </ul>
        </div>
        
        <div class="card red-flag">
            <h2>2. Immediate Actions & Red Flags</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 30%;">Action</th>
                        <th>Details & Triggers</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Pregnancy Test</strong></td>
                        <td><span class="highlight">Mandatory</span> for all to exclude ectopic pregnancy.</td>
                    </tr>
                    <tr>
                        <td><strong>Urgent Hospital Admission</strong></td>
                        <td>Admit immediately if any of the following are present:
                            <ul>
                                <li>Pregnancy confirmed or ectopic cannot be excluded.</li>
                                <li>Severe systemic illness (high fever, vomiting, signs of peritonitis).</li>
                                <li>Palpable adnexal mass (suspected tubo-ovarian abscess).</li>
                                <li>Uncertain diagnosis where surgical emergencies cannot be ruled out.</li>
                                <li>Unable to tolerate oral treatment regimen.</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="card management">
            <h2>3. Outpatient Management & Treatment</h2>
            <p>If no red flags for admission, proceed with outpatient care. Start empirical antibiotics immediately after taking swabs.</p>
            
            <h3>Antibiotic Regimens (14-Day Course)</h3>
            <table>
                <thead>
                    <tr>
                        <th>Tier / Condition</th>
                        <th>Recommended Regimen</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>First-Line</strong> (Low/High Gonorrhoea Risk)</td>
                        <td><strong>Ceftriaxone</strong> 1g IM (single dose)<br><strong>PLUS</strong><br><strong>Doxycycline</strong> 100mg twice daily<br><strong>PLUS</strong><br><strong>Metronidazole</strong> 400mg twice daily</td>
                    </tr>
                    <tr>
                        <td><strong>Second-Line</strong></td>
                        <td><strong>Ofloxacin</strong> 400mg twice daily + <strong>Metronidazole</strong> 400mg twice daily<br><strong>OR</strong><br><strong>Moxifloxacin</strong> 400mg once daily</td>
                    </tr>
                    <tr>
                        <td><strong>If M. genitalium Confirmed</strong></td>
                        <td><strong>Moxifloxacin</strong> 400mg once daily</td>
                    </tr>
                </tbody>
            </table>
            <div class="warning-text">
                <strong>MHRA Warning:</strong> Fluoroquinolones (Ofloxacin, Moxifloxacin) carry a risk of disabling and irreversible side effects. Prescribe only when other antibiotics are inappropriate and provide patient safety information.
            </div>
        </div>
        
        <div class="card">
            <h2>4. Patient Advice</h2>
            <ul>
                <li><strong>Pain Relief:</strong> Recommend paracetamol and/or ibuprofen.</li>
                <li><strong>Sexual Contact:</strong> Abstain from all intercourse until both patient and partner(s) complete treatment and are symptom-free.</li>
                <li><strong>Contraception:</strong> Advise barrier methods to reduce future STI risk.</li>
                <li><strong>IUD/IUS in situ:</strong>
                    <ul>
                        <li><span class="highlight">Mild/Moderate PID:</span> Can remain. Reassess in 72 hours; if no improvement, remove.</li>
                        <li><span class="highlight">Severe PID:</span> Remove immediately. Consider emergency contraception if removed.</li>
                    </ul>
                </li>
            </ul>
        </div>
        
        <div class="card">
            <h2>5. Partner Management</h2>
            <ul>
                <li>All sexual partners from the <strong>last 6 months</strong> require screening and treatment.</li>
                <li>Advise partners to attend a specialist sexual health service.</li>
                <li>If managed in primary care, offer empirical treatment: <span class="highlight">Doxycycline 100mg twice daily for 7 days</span> while awaiting test results.</li>
            </ul>
        </div>

        <div class="card">
            <h2>6. Follow-Up</h2>
            <h3>Review within 72 hours</h3>
            <ul>
                <li>Assess for clinical improvement. If not improving, check compliance, reassess diagnosis, and consider admission.</li>
                <li>Review swab results and adjust antibiotics based on sensitivities if needed.</li>
            </ul>
            <h3>Arrange "Test of Cure" (TOC)</h3>
            <ul>
                <li><strong>Gonorrhoea:</strong> TOC 2-4 weeks post-treatment.</li>
                <li><strong>M. genitalium:</strong> TOC 4 weeks post-treatment.</li>
                <li><strong>Chlamydia:</strong> TOC 3-5 weeks post-treatment <strong>only if</strong> symptoms persist, compliance was poor, or re-exposure is suspected.</li>
            </ul>
        </div>
        
        <footer>
            <p>This is a clinical aide for quick reference and does not replace full clinical guidelines or professional judgment. Based on NICE CKS on Pelvic Inflammatory Disease.</p>
        </footer>
    </div>

</body>
</html>